The primary pain point is the severe scarcity of high-quality, annotated medical imaging data. Real patient scans are siloed due to HIPAA compliance, expensive to label by expert radiologists, and often lack sufficient examples of rare pathologies. This data bottleneck stalls AI development, limits model generalizability, and creates significant financial and competitive risk for health systems investing in diagnostic AI. Without diverse training data, models fail in real-world clinical settings.













